// App-Quantinova.ai

4027 : Recurrent gains of CD274 (PD-L1) and PDCD1LG2 (PD-L2) provide a genetic basis for PD-1 ligand expression in a subset of solid tumors

Researchers

Presenter

  • Evisa Gjini

Principal Investigators

  • Christine Pak

  • Alyssa Kelly

  • Yuling Shi

  • Neal Lindeman

  • Frank Kuo

  • Gordon Freeman

  • Azra Ligon

  • Stephen Hodi

  • Margaret Shipp

  • Scott Rodig

Medical Centers

  • Dana-Farber Cancer Institute, Boston, MA

  • Brigham & Women's Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death 1 ligand 2

  • Programmed cell death protein 1

  • Programmed death-ligand 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved